在PI3Kα C-终端激活的自由能量景观
Danai Maria Kotzampasi1,2, Michail Papadourakis1, John E Burke3,4
1Biomedical Research Foundation, Academy of Athens, Athens 11527, Greece.
Computational and structural biotechnology journal
|September 4, 2024
概括
这就是PIK3CA基因.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- PIK3CA基因编码PI3Kα的p110α催化子单元,PI3Kα是细胞信号传递中的关键酶.
- 在癌症中,PIK3CA的突变很常见,特别是在激酶域的C端,导致过度激活.
- 通过C端PIK3CA突变驱动瘤发生的精确分子机制尚未完全理解.
研究的目的:
- 阐明由C端突变引起的PI3Kα过度激活的分子机制.
- 为了比较野生型 (WT) PI3Kα与各种C端突变的激酶活性和构造变化.
- 为开发向癌症治疗提供分子基础.
主要方法:
- 使用无偏见和偏见的分子动力学 (MD) 模拟来研究PI3Kα C终端突变物.
- 对于WT和突变形式,计算了C终端"关闭到开放"过渡的自由能量景观.
- 结果与实验性-乳交换质谱 (HDX-MS) 数据进行了验证.
主要成果:
- 与WT,M1043L和N1068KLKR突变相比,MD模拟显示了H1047R和G1049R突变的C端重定向的独特机制.
- H1047R突变增加了全结合体结合口袋的可访问性.
- 模拟结果与实验HDX-MS数据保持一致,支持拟议的机制.
结论:
- 这项研究提供了关于C端PIK3CA突变如何激活PI3Kα的分子见解.
- 这些发现澄清了特定突变对酶构成和活性的影响.
- 这项研究作为设计突变特异PI3Kα抑制剂用于癌症治疗的基础.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
IP3/DAG Signaling Pathway
11.9K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
11.9K
Amplifying Signals via Enzymatic Cascade
8.4K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.4K
Phosphoinositides and PIPs
8.5K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.5K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


